| Glecaprevir/Pibrentasvir Fixed-dose Combination Treatment for Acute Hepatitis C Virus Infection (NCT04042740) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2019-11-20 |
| Feasibility of Implementing a Cohort of People Living With Hepatitis C in Vietnam (NCT03601546) | Centre Hospitalier Universitaire de Nīmes | 2018-09-13 |
| Effectiveness, Safety and Clinical Outcomes of Paritaprevir/Ombitasvir/r+Dasabuvir 8 Weeks (NCT03122132) | Hepa C | 2017-02-20 |
| Pembrolizumab (MK-3475) in Hepatocellular Carcinoma (NCT02940496) | M.D. Anderson Cancer Center | 2016-12-09 |
| Hepatitis C Infection in World Trade Center Responders (NCT02982993) | Icahn School of Medicine at Mount Sinai | 2016-12-01 |
| DNA Vaccine Therapy in Treating Patients With Chronic Hepatitis C Virus Infection (NCT02772003) | National Cancer Institute (NCI) | 2016-06-06 |
| A Study to Evaluate Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in Treatment-Naïve Hepatitis C Virus Genotype 1b-Infected Adults (NCT02582632) | AbbVie | 2015-11-24 |
| A Study to Assess the Safety of Hep C Vaccine Candidates in HIV Seropositive Individuals (NCT02568332) | University of Oxford | 2015-07-21 |
| Outcomes in Liver Disease Patient With and Without HIV Co-infection-Sub Study 2: HCV Treatment: Health Related Quality (NCT02427204) | Icahn School of Medicine at Mount Sinai | 2015-06-01 |
| Effects of Persistent Innate Immune Activation on Vaccine Efficacy (NCT02429583) | Rockefeller University | 2015-05-08 |
| Navitoclax and Sorafenib Tosylate in Treating Patients With Relapsed or Refractory Solid Tumors (NCT02143401) | National Cancer Institute (NCI) | 2015-01-30 |
| Safety Study of the Aethlon Hemopurifier (NCT02215902) | Aethlon Medical Inc. | 2014-12-01 |
| A Bioequivalence Study of Daclatasvir Tablets and Bioavailability Studies of Daclatasvir and Asunaprevir (NCT02323594) | Bristol-Myers Squibb | 2014-12-01 |
| Coadministration of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) With Ribavirin (RBV) in Adults With Genotype 4 (GT4) Hepatitis C Virus (HCV) in Egypt (NCT02247401) | AbbVie | 2014-11-04 |
| A Study to Assess the Safety of HIV and Hep C Vaccine Candidates When Given Separately or in Combination (NCT02362217) | University of Oxford | 2014-10-01 |
| HCV-HIV Co-infected Patient Cohort in Thailand (NCT02247440) | Institut de Recherche pour le Developpement | 2014-08-01 |
| Sofosbuvir, Ribavirin, for the Treatment of Chronic Hepatitis C Virus Genotype 1 in HIV-Coinfected Patients Receiving Fixed Dose Co-formulation Emtricitabine/ Tenofovir/Cobicistat/Elvitegravir: A Pilot Study (NCT02220868) | Saint Michael's Medical Center | 2014-07-01 |
| Study of Efficacy and Safety of Grazoprevir (MK-5172) + Elbasvir (MK-8742) With or Without Ribavirin for Participants With Hepatitis C Genotype 1, 4, or 6 Infections Who Have Failed Prior Treatment With Pegylated Interferon + Ribavirin (MK-5172-068) (NCT02105701) | Merck Sharp & Dohme LLC | 2014-06-05 |
| Study of Drug Combination on Pharmacokinetics in Healthy Volunteers (NCT02175602) | Bristol-Myers Squibb | 2014-06-01 |
| Safety, Pharmacokinetics, and Pharmacodynamics of Ruzasvir (MK-8408) in Participants With Hepatitis C Infection (MK-8408-003) (NCT02076100) | Merck Sharp & Dohme LLC | 2014-03-27 |
| Boceprevir in End Stage Renal Disease (ESRD) (NCT02112630) | Columbia University | 2013-05-01 |
| Interaction Between Paroxetine and Telaprevir (NCT01841502) | Radboud University Medical Center | 2013-05-01 |
| Open Label Study of the Efficacy and Safety of MBL-HCV1 in Combination With Oral Direct-Acting Antivirals in Patients Undergoing Liver Transplantation for Hepatitis C (NCT01532908) | MassBiologics | 2012-11-21 |
| Study of Hepatitis C Virus (HCV) Entry Inhibitor in Liver Transplant Recipients With HCV Infection (NCT01560468) | Schiano, Thomas D., MD | 2012-03-01 |
| Treating Hispanic Patients Diagnosed With Hepatitis C Using Boceprevir (NCT01465516) | Arrowhead Regional Medical Center | 2011-11-01 |
| Effects of Vitamin D on Inflammation in Liver Disease (NCT01754961) | Veterans Medical Research Foundation | 2011-11-01 |
| Comparison of Two Triple Regimens for Treatment and Retreatment of Chronic Hepatitis C Infection (NCT01771653) | Southern Illinois University | 2011-09-01 |
| 36 vs 48 Wks Peg-Intron Plus Ribavirin for HCV Patients Without Rapid Virologic Response But Without HCV RNA at wk 8 (NCT01683786) | Chang Gung Memorial Hospital | 2011-08-01 |
| Study of a New MVA Vaccine for Hepatitis C Virus (NCT01296451) | ReiThera Srl | 2010-12-01 |
| Study of SCY-635, Pegasys and Copegus in Hepatitis C (NCT01265511) | Scynexis, Inc. | 2010-11-01 |
| A Safety and Tolerability Study of Nitazoxanide in HIV-HCV Treatment Failures (NCT01185028) | National Institutes of Health Clinical Center (CC) | 2010-08-01 |
| Romiplostim in Treating Hepatitis C-Infected Patients With Thrombocytopenia (NCT01153919) | University of Southern California | 2010-06-30 |
| An Anti-viral Combination Study With Japanese Hepatitis C Infection (HCV) Subject (NCT01051414) | Bristol-Myers Squibb | 2010-04-01 |
| Nitazoxanide Plus Ribavirin and Peginterferon for Therapy of Treatment Naive HCV Genotype 1 and HIV Coinfected Subjects (NCT00991289) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-01-01 |
| Safety and Efficacy of Daclatasvir (BMS-790052) Plus Standard of Care in Japanese Patients (Pegylated-interferon Alpha-2a and Ribavirin) (NCT01017575) | Bristol-Myers Squibb | 2009-12-01 |
| Safety and Efficacy of Daclatasvir (BMS-790052) Plus Standard of Care (Pegylated-interferon Alpha-2b and Ribavirin) in Japanese Patients (NCT01016912) | Bristol-Myers Squibb | 2009-12-01 |
| Safety and Efficacy of Daclatasvir (BMS-790052) Plus Standard of Care (Pegylated-interferon Alpha and Ribavirin) (NCT00874770) | Bristol-Myers Squibb | 2009-06-01 |
| Liver Cancer Prevention Trial in Patients With Chronic Hep C Infection (NCT00513461) | Chao Family Comprehensive Cancer Center | 2007-10-01 |
| An Hepatitis B Vaccine Model for HIV Vaccine Trials in Drug Users (NCT00841477) | National Institute on Drug Abuse (NIDA) | 2004-01-01 |